“The U.S. lost progress combating antimicrobial resistance in 2020 due, in large part, to effects of the COVID-19 pandemic. The CDC COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022 [PDF – 44 pages], concluded that the threat of antimicrobial-resistant infections is not only still present but has gotten worse.”  ...

... COVID-19 Impact on Five Core Actions to Combat Resistance

CDC targets five core actions to better prepare the U.S. to combat antimicrobial resistance, integrating a One Health approach to comprehensively tackle new threats that will continue to emerge worldwide. The pandemic impacted these core actions. ... “